Related references
Note: Only part of the references are listed.Feasibility of HER2-Targeted Therapy in Advanced Biliary Tract Cancer: A Prospective Pilot Study of Trastuzumab Biosimilar in Combination with Gemcitabine Plus Cisplatin
Hyehyun Jeong et al.
CANCERS (2021)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
A meta-analysis of the efficacy of postoperative adjuvant radiotherapy versus no radiotherapy for extrahepatic cholangiocarcinoma and gallbladder carcinoma
Bixin Ren et al.
RADIATION ONCOLOGY (2020)
Neoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysis
Changhoon Yoo et al.
BRITISH JOURNAL OF CANCER (2020)
Phase II study assessing tolerability, efficacy, and biomarkers for durvalumab (D) ± tremelimumab (T) and gemcitabine/cisplatin (GemCis) in chemo-naïve advanced biliary tract cancer (aBTC).
Do-Youn Oh et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Molecular targeted therapies: Ready for prime time in biliary tract cancer
Angela Lamarca et al.
JOURNAL OF HEPATOLOGY (2020)
Prediction of Cancer Incidence and Mortality in Korea, 2020
Kyu-Won Jung et al.
CANCER RESEARCH AND TREATMENT (2020)
Ivosidenib in IDH1-mutant, chemotherapy-refractory Croatia& cholangiocarcinoma (ClarlDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
Ghassan K. Abou-Alfa et al.
LANCET ONCOLOGY (2020)
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
Ghassan K. Abou-Alfa et al.
LANCET ONCOLOGY (2020)
Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancer
Changhoon Yoo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Response to the comment on “Number and Station of Lymph Node Metastasis After Curative-intent Resection of Intrahepatic Cholangiocarcinoma Impact Prognosis”
Xu-Feng Zhang et al.
ANNALS OF SURGERY (2020)
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesus M. Banales et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma
Changhoon Yoo et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Impact of Anatomical Versus Non-anatomical Liver Resection on Short- and Long-Term Outcomes for Patients with Intrahepatic Cholangiocarcinoma
Anfeng Si et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study
Julien Edeline et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline
Rachna T. Shroff et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
John N. Primrose et al.
LANCET ONCOLOGY (2019)
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial
Rachna T. Shroff et al.
JAMA ONCOLOGY (2019)
Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker
Heejung Chae et al.
EUROPEAN JOURNAL OF CANCER (2019)
Adjuvant Therapy Is Associated With Improved Survival in Resected Perihilar Cholangiocarcinoma: A Propensity Matched Study
Ibrahim Nassour et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer
T. Ebata et al.
BRITISH JOURNAL OF SURGERY (2018)
Trends in use of lymphadenectomy in surgery with curative intent for intrahepatic cholangiocarcinoma
X-F Zhang et al.
BRITISH JOURNAL OF SURGERY (2018)
Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-Line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer
Changhoon Yoo et al.
CANCER RESEARCH AND TREATMENT (2018)
Optimal surgical treatment in patients with T1b gallbladder cancer: An international multicenter study
Hyeong Seok Kim et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2018)
Intrahepatic cholangiocarcinoma: the AJCC/UICC 8th edition updates
Andrew J. Lee et al.
CHINESE CLINICAL ONCOLOGY (2018)
The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts
Hop S. Tran Cao et al.
CANCER (2018)
Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy
Xu-Feng Zhang et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2017)
Limited Use of Adjuvant Therapy in Patients With Resected Gallbladder Cancer Despite a Strong Association With Survival
Timur Mitin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Limited Use of Adjuvant Therapy in Patients With Resected Gallbladder Cancer Despite a Strong Association With Survival
Timur Mitin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients
Bum Jun Kim et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Efficacy of fluoropyrimidine-based chemotherapy in patients with advanced biliary tract cancer after failure of gemcitabine plus cisplatin: retrospective analysis of 321 patients
Bum Jun Kim et al.
BRITISH JOURNAL OF CANCER (2017)
Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J. W. Valle et al.
ANNALS OF ONCOLOGY (2016)
Correlations of survival with progression-free survival, response rate, and disease control rate in advanced biliary tract cancer: a meta-analysis of randomised trials of first-line chemotherapy
Toshikazu Moriwaki et al.
BRITISH JOURNAL OF CANCER (2016)
Adjuvant Chemotherapy and Radiation Therapy is Associated with Improved Survival for Patients with Extrahepatic Cholangiocarcinoma
Richard S. Hoehn et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma
Edgar Ben-Josef et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Intrahepatic Cholangiocarcinoma: Prognosis of Patients Who Did Not Undergo Lymphadenectomy
Fabio Bagante et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2015)
Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review
Joon Oh Park et al.
CANCER RESEARCH AND TREATMENT (2015)
Surgical Strategy for T2 Gallbladder Cancer According to Tumor Location
Huisong Lee et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Surgical Strategy for T1 Gallbladder Cancer: A Nationwide Multicenter Survey in South Korea
Seung Eun Lee et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Role of Cholecystectomy and Lymph Node Dissection in Patients with T2 Gallbladder Cancer
Dong Hyun Kim et al.
WORLD JOURNAL OF SURGERY (2013)
Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis
Anne M. Horgan et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment
Mechteld C. de Jong et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Incidental Gallbladder Cancer by the AFC-GBC-2009 Study Group
David Fuks et al.
WORLD JOURNAL OF SURGERY (2011)
Aggressive Surgical Resection for Hilar Cholangiocarcinoma of the Left-Side Predominance Radicality and Safety of Left-Sided Hepatectomy
Hiroaki Shimizu et al.
ANNALS OF SURGERY (2010)
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
T. Okusaka et al.
BRITISH JOURNAL OF CANCER (2010)
Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience
Sung Gyu Lee et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2010)
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
Juan Valle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Hilar Cholangiocarcinoma: Current Management
Fumito Ito et al.
ANNALS OF SURGERY (2009)
Analysis of the Extent of Resection for Adenocarcinoma of the Gallbladder
Michael D'Angelica et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Radical resection for T1b gallbladder cancer: a decision analysis
Michael A. Abramson et al.
HPB (2009)
Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer
Samuel J. Wang et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Surgical approach to bismuth type I and II hilar cholangiocarcinomas
Takashi Ikeyama et al.
ANNALS OF SURGERY (2007)
Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome
D. Ribero et al.
BRITISH JOURNAL OF SURGERY (2007)
Cholangiocarcinoma - Thirty-one-year experience with 564 patients at a single institution
Michelle L. DeOliveira et al.
ANNALS OF SURGERY (2007)
Anatomic right hepatic trisectionectomy (extended right hepatectomy) with caudate lobectomy for hilar cholangiocarcinoma
M Nagino et al.
ANNALS OF SURGERY (2006)
Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure - A prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors
KTC Tran et al.
ANNALS OF SURGERY (2004)
Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma - Implications for adjuvant therapeutic strategies
WR Jarnagin et al.
CANCER (2003)
Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma
T Takada et al.
CANCER (2002)
Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2 - Randomized controlled trial evaluating survival, morbidity, and mortality
CJ Yeo et al.
ANNALS OF SURGERY (2002)
Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma
M Shimada et al.
BRITISH JOURNAL OF SURGERY (2001)
Prognostic significance of lymph node involvement in middle and distal bile duct cancer
R Sasaki et al.
SURGERY (2001)
Share Paper
